Cross Over Convenience And Preference Study Of New Mark VII Compared To Genotropin Pen In Pediatric And Adult Subjects

A Multicenter, Open-label, Randomized Two Arm Cross Over Study Assessing Dyad (Subject and Caregiver) and Adult Subject Perception of Convenience and Preference of the Newly Developed Genotropin Mark VII Pen.

Convenience and preference for the new Mark VII pen compared to the current Genotropin pen will be assessed using a questionaire. it is expected that the new pen will be preferred or at least no different to the current pen.

Inclusion Criteria:

• Age greater than or equal to 8 years.
• Subjects who are starting treatment with growth hormone (Genotropin) for the first time.

Exclusion Criteria:

• Subjects with Prader-Willi syndrome or chronic renal insufficiency.
• Subjects and caregivers who, in the opinion of the investigator are not able to adequately participate in the study.
• Subjects with chronic systemic disorders, such as diabetes and heart disease.